These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19851024)

  • 1. How to get the magic triangle and the MAD triangle into your protein crystal.
    Beck T; da Cunha CE; Sheldrick GM
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Oct; 65(Pt 10):1068-70. PubMed ID: 19851024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The magic triangle goes MAD: experimental phasing with a bromine derivative.
    Beck T; Gruene T; Sheldrick GM
    Acta Crystallogr D Biol Crystallogr; 2010 Apr; 66(Pt 4):374-80. PubMed ID: 20382990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining random microseed matrix screening and the magic triangle for the efficient structure solution of a potential lysin from bacteriophage P68.
    Truong JQ; Panjikar S; Shearwin-Whyatt L; Bruning JB; Shearwin KE
    Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):670-681. PubMed ID: 31282476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatization of Protein Crystals with I3C using Random Microseed Matrix Screening.
    Truong JQ; Nguyen S; Bruning JB; Shearwin KE
    J Vis Exp; 2021 Jan; (167):. PubMed ID: 33522501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Amino-2,4,6-tribromoisophthalic acid: the MAD triangle for experimental phasing.
    Beck T; Herbst-Irmer R; Sheldrick GM
    Acta Crystallogr C; 2009 May; 65(Pt 5):o237-9. PubMed ID: 19407425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A magic triangle for experimental phasing of macromolecules.
    Beck T; Krasauskas A; Gruene T; Sheldrick GM
    Acta Crystallogr D Biol Crystallogr; 2008 Nov; 64(Pt 11):1179-82. PubMed ID: 19020357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified heavy-atom derivatization of protein structures via co-crystallization with the MAD tetragon tetrabromoterephthalic acid.
    Truong JQ; Nguyen S; Bruning JB; Shearwin KE
    Acta Crystallogr F Struct Biol Commun; 2021 May; 77(Pt 5):156-162. PubMed ID: 33949976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-house high-energy-remote SAD phasing using the magic triangle: how to tackle the P1 low symmetry using multiple orientations of the same crystal of human IBA57 to increase the multiplicity.
    Gourdoupis S; Nasta V; Ciofi-Baffoni S; Banci L; Calderone V
    Acta Crystallogr D Struct Biol; 2019 Mar; 75(Pt 3):317-324. PubMed ID: 30950402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane protein structure determination by SAD, SIR, or SIRAS phasing in serial femtosecond crystallography using an iododetergent.
    Nakane T; Hanashima S; Suzuki M; Saiki H; Hayashi T; Kakinouchi K; Sugiyama S; Kawatake S; Matsuoka S; Matsumori N; Nango E; Kobayashi J; Shimamura T; Kimura K; Mori C; Kunishima N; Sugahara M; Takakyu Y; Inoue S; Masuda T; Hosaka T; Tono K; Joti Y; Kameshima T; Hatsui T; Yabashi M; Inoue T; Nureki O; Iwata S; Murata M; Mizohata E
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13039-13044. PubMed ID: 27799539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an alternative approach to protein crystallization.
    McPherson A; Nguyen C; Larson SB; Day JS; Cudney B
    J Struct Funct Genomics; 2007 Dec; 8(4):193-8. PubMed ID: 18038192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure determination of the cancer-associated Mycoplasma hyorhinis protein Mh-p37.
    Sippel KH; Robbins AH; Reutzel R; Domsic J; Boehlein SK; Govindasamy L; Agbandje-McKenna M; Rosser CJ; McKenna R
    Acta Crystallogr D Biol Crystallogr; 2008 Nov; 64(Pt 11):1172-8. PubMed ID: 19020356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Many Ways to Derivatize Macromolecules and Their Crystals for Phasing.
    Dauter M; Dauter Z
    Methods Mol Biol; 2017; 1607():349-356. PubMed ID: 28573580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the influence of crystal size and wavelength on native SAD phasing.
    Liebschner D; Yamada Y; Matsugaki N; Senda M; Senda T
    Acta Crystallogr D Struct Biol; 2016 Jun; 72(Pt 6):728-41. PubMed ID: 27303793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental Phasing: Substructure Solution and Density Modification as Implemented in SHELX.
    Thorn A
    Methods Mol Biol; 2017; 1607():357-376. PubMed ID: 28573581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collection of X-Ray Diffraction Data from Macromolecular Crystals.
    Dauter Z
    Methods Mol Biol; 2017; 1607():165-184. PubMed ID: 28573573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel strategy for the crystallization of proteins: X-ray diffraction validation.
    Larson SB; Day JS; Cudney R; McPherson A
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):310-8. PubMed ID: 17327668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACORN in CCP4 and its applications.
    Yao JX
    Acta Crystallogr D Biol Crystallogr; 2002 Nov; 58(Pt 11):1941-7. PubMed ID: 12393926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of protein crystals for X-ray structural study.
    Takeda S
    Methods Mol Med; 2006; 129():291-303. PubMed ID: 17085819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAD phasing with krypton.
    Cohen A; Ellis P; Kresge N; Soltis SM
    Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):233-8. PubMed ID: 11173469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of layer silicate for protein crystallization: effects of Micromica and chlorite powders in hanging drops.
    Takehara M; Ino K; Takakusagi Y; Oshikane H; Nureki O; Ebina T; Mizukami F; Sakaguchi K
    Anal Biochem; 2008 Feb; 373(2):322-9. PubMed ID: 18054772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.